For licensed medical professionals and compounding pharmacies only. Not for sale to the general public.  ·  787-822-8197
Build Your Order Apply for Wholesale
Build Your Order Products For Clinics For Pharmacies For Brands Quality Wholesale Resources About Contact Apply for Wholesale
Product sourcing reference

CJC-1295 / Ipamorelin Blend

A two-peptide reference combining CJC-1295 without DAC and ipamorelin. Review each component separately before treating the blend as a single item.

Reference variants

Add CJC-1295 / Ipamorelin Blend to an order request

Quantities are individual vials (packs of 10). Orders need 100 vials and/or 20 spray bottles in total, mixed across items. Prices are reference estimates captured 2026-10-16; every request is pending eligibility and availability review. Per-unit figures are rounded to the cent from kit pricing, so a final quote may differ slightly.

  • CJC-1295 without DAC / Ipamorelin Blend 10mg (5/5)Vial · confirm physical formCAS 863288-34-0
    $23.00/vial$18.40/vial at 1,000+ vials of this item
    vials, packs of 10

Review your order request · Compare the full catalog

Confirm the exact substance

The blend pairs a GHRH analogue (modified GRF 1-29) with a ghrelin-receptor agonist. The ratio and the absence of DAC matter for comparing it with other listings.

What the review will ask

Neither component is an approved medicine. Combining them does not create an approved product or a compounding basis.

  • State the facility type, destination state and intended transaction. Do not send patient information.
  • Expect product- and lot-specific documentation to be requested before any material is accepted.
  • A listed price is a reference estimate. Availability, labeling, shipping and terms are confirmed in writing only after review.

Purchasing questions

Does this blend contain CJC-1295 with DAC?

No. The listed blend uses the no-DAC form. Confirm the component identity on the specification before requesting it.

Specify both identities in the blend

The reference describes a no-DAC CJC component with ipamorelin. FDA's safety discussion includes CJC-1295 and ipamorelin acetate; combining them does not resolve those concerns.

Documentation to request

Ask for per-component amounts, the identity and salt of each component and the basis for compatibility. Do not use the combined 10mg total as either component's quantity.

Regulatory context: FDA: substance-specific safety concerns. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.

Related guidance: Hormone clinic purchasing review. These references support a review, not a treatment recommendation or supply authorization.

Verify the current regulatory position

Use FDA human drug compounding guidance and applicable state requirements. This reference is not medical or legal advice and does not establish a lawful supply route.

Discuss sourcing requirements
Call Apply for Wholesale